Heston Blumenthal creates menu for appetite suppressant users

UK – Renowned chef Heston Blumenthal has launched a new tasting menu, The Mindful Experience, tailored for diners taking weight loss and appetite suppressant medications.

Priced at £275 ($370, €315) per head, the menu offers a scaled-back version of Blumenthal’s flagship Journey tasting menu at The Fat Duck while preserving its signature texture and flavour.

‘Millions of people are eating much less food, drinking less, losing interest in restaurants, losing interest even in food,’ says Blumenthal, highlighting how these medications are reshaping consumer behaviour. The chef uses weight loss drugs himself to manage weight gain caused by bipolar medication, giving him first-hand insight into the changing needs of diners.

As noted in LS:N Global’s Neozempic Futures and Weight Loss Market Futures reports, the rise of appetite suppressant use – including drugs such as semaglutide – is transforming industries worldwide, from food service to hospitality.

Consumers are increasingly seeking mindful eating, wellness-focused dining and lower-calorie options, presenting opportunities for chefs and brands to rethink menus, portions and the overall dining experience.